← FDA Drug Approvals (Drugs@FDA)

YARGESA

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EDENBRIDGE PHARMS · Approved 2020-08-06

Drug application

FDA Application #

ANDA209821

Application type

Abbreviated New Drug Application (Generic)

Brand name

YARGESA

Generic name

MIGLUSTAT

Active ingredients

MIGLUSTAT

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

EDENBRIDGE PHARMS

Manufacturer

Edenbridge Pharmaceuticals LLC.

First approval

2020-08-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown